Maa: Kanada
Kieli: ranska
Lähde: Health Canada
Bromure de rocuronium
STERIMAX INC
M03AC09
ROCURONIUM BROMIDE
10MG
Solution
Bromure de rocuronium 10MG
Intraveineuse
10X5ML
Prescription
NEUROMUSCULAR BLOCKING AGENTS
Numéro de groupe d'ingrédients actifs (GIA) :0126317001; AHFS:
APPROUVÉ
2023-03-02
3 VU 02125 3,((3528,7 3U URPXUHGH URFXURQLXPLQMHF DEOH PJ P/ 6ROXLRQV pULOH SRXU LQMHF LRQ ORTXHXUQHXURPXVFXODLUH VTXHOH LTXHQRQGpSRODULVDQ DQDGD-;3 9DUHQQHV4XHEHF %RXO /LRQHO %RXOHW 6WULGHV 3KDUPD DQDGD,QF 1 R GH FRQWUOH GH ODSUpVHQWDWLRQ 14 PDL 3 VU 7DEOHGHV PDLqUHV 357,(, 5(16(,1(0(176 3285 /( 352)(66,211(/( / 6 17e 5(16(, 1(0(176 6200 ,5(6 685/(352'8,7 ,1', 7,216 (7 86 ( /,1,48( 2175( ,1',7,216 0,6(6(15'((7 35e 87,216 ())(76 ,1'e6,5%/(6 ,17(57,2160e', 0(17(86(6 3262/2,( (7 '0,1,6757,21 685'26( 02'( ' 7,21(7 3 50 2/2,( /,1,48( 67%,/,7e (7 (175(326 ( ',5( 7,9(6 357, 8/, 5(6 '(01,38/7,21 )250(6 3262/2 ,48(6 20326,7,21 (7 21',7,211(0(17 357,( ,, 5(16(, 1(0(176 6,(17,),48(6 5(16(, 1(0(176 350 (87,48(6 e78'(6 /,1,48(6 350 2/2,( 'e7 ,//e( 72;, 2/2,( 357,(,,, 5(16(, 1(0(1763285/( 2162007(85 3 VU 3U 52085( (528521,80,1-(7 /( URPXUH GH URFXURQLXP 357,( , 5(16(,1(0(176 3285/(352)(66,211(/( / 6 17e 5(16(, 1(0(1766200,5(6 685/( 3528,7 RLH GDGPLQLVUDLRQ )RUPH SRVRORJLTXH HQHXU 7RXVOHV LQJUpGLHQV QRQPpGLFLQDX ,QWUDYHLQHXVH 6ROXWLRQ SRXU LQMHFWLRQ PJ P/ FpWDWH GH VRGLXP WULKGUDWp FKORUXUH GH VRGLXP HDX SRXU SUpSDUDWLRQV LQMHFWDEOHV D]RWH 3HXW FRQWHQLU GH ODFLGH DFpWLTXH JODFLDO SRXU DMXVWHU OH S j HQYLURQ ,1 , 7,216(7 86(/,1,48( /H EURPXUH GH URFXURQLXP LQMHFWDEOH HVW LQGLTXp FRPPH WUDLWHPHQW GDSSRLQW ORUV GXQH DQHVWKpVLH JpQpUDOH GDQV OH EXW GH IDFLOLWHU OLQWXEDWLRQ HQGRWUDFKpDOH QRUPDOH RX OLQWXEDWLRQ HQGRWUDFKpDOH j VpTXHQFH UDSLGH FRPPHQFpH j VHFRQGHV DSUqV O DGPLQLVWUDWLRQ DILQ GH SURFXUHU XQ UHOkFKHPHQW GHV PXVFOHV VTXHOHWWLTXHVSHQGDQW XQH LQWHUYHQWLRQFKLUXUJLFDOHRX XQH YHQWLODWLRQ PpFDQLTXH /H EURPXUH GH URFXURQLXP HVW XQ EORTXHXU QHXURPXVFXODLUH QRQ GpSRODULVDQW GRWp GXQ GpEXW GDFWLRQ UDSLGH j LQWHUPpGLDLUH HW G XQH GXUpH G DFWLRQ LQWHUPpGLDLUH VHORQ OD GRVH 3HUVRQQHVkJpHV DQV 'HV GRVHV GHQWUHWLHQ HW GHV GpELWV GH SHUIXVLRQ SOXV IDLEOHV VRQW UHFRPPDQGpVFDU OD GXUpH GX EORF QHXURPXVFXODLUH HVW JpQpUDOHPHQW SOXV ORQJXH FKH] OHV SHUVRQQHV kJpHV 3RXU REWHQLU GH SOXV DPSOHV GpWDLOV YRLU OD VHFWLRQ 3262/2,((7 0,1,6757,213H Lue koko asiakirja